CN101309913B - 制备地莫匹醇及其衍生物的方法 - Google Patents
制备地莫匹醇及其衍生物的方法 Download PDFInfo
- Publication number
- CN101309913B CN101309913B CN2006800430395A CN200680043039A CN101309913B CN 101309913 B CN101309913 B CN 101309913B CN 2006800430395 A CN2006800430395 A CN 2006800430395A CN 200680043039 A CN200680043039 A CN 200680043039A CN 101309913 B CN101309913 B CN 101309913B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- sodium
- iii
- delmopinol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 229960003854 delmopinol Drugs 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims description 73
- 239000000203 mixture Substances 0.000 claims description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 20
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 20
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 13
- 229910052794 bromium Inorganic materials 0.000 claims description 11
- 229910052740 iodine Inorganic materials 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 5
- 238000006722 reduction reaction Methods 0.000 claims description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 4
- 150000001721 carbon Chemical group 0.000 claims description 4
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- UIICPZFWHBJNIG-UHFFFAOYSA-N sodium;2-methoxyethanolate Chemical compound [Na+].COCC[O-] UIICPZFWHBJNIG-UHFFFAOYSA-N 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract description 27
- 239000000543 intermediate Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000012453 solvate Substances 0.000 abstract description 2
- 239000007818 Grignard reagent Substances 0.000 abstract 2
- 150000004795 grignard reagents Chemical class 0.000 abstract 2
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 abstract 2
- 229960000649 oxyphenbutazone Drugs 0.000 abstract 2
- 239000012458 free base Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 58
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 19
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 9
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 8
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 150000002780 morpholines Chemical class 0.000 description 4
- 238000005580 one pot reaction Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- VIJYGBOPLCWXPJ-UHFFFAOYSA-N 2-(3-heptylmorpholin-4-yl)ethanol Chemical compound CCCCCCCC1COCCN1CCO VIJYGBOPLCWXPJ-UHFFFAOYSA-N 0.000 description 3
- JFZBMJJFVBMZNC-UHFFFAOYSA-N 2-[3-(4-propylheptyl)morpholin-4-yl]ethanol;hydrochloride Chemical compound Cl.CCCC(CCC)CCCC1COCCN1CCO JFZBMJJFVBMZNC-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- VSEAAEQOQBMPQF-UHFFFAOYSA-N morpholin-3-one Chemical compound O=C1COCCN1 VSEAAEQOQBMPQF-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- LSXKDWGTSHCFPP-UHFFFAOYSA-N 1-bromoheptane Chemical compound CCCCCCCBr LSXKDWGTSHCFPP-UHFFFAOYSA-N 0.000 description 1
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 1
- OUKZCLWTXYJXGZ-UHFFFAOYSA-N 1-butoxybutane;1,2-xylene Chemical compound CC1=CC=CC=C1C.CCCCOCCCC OUKZCLWTXYJXGZ-UHFFFAOYSA-N 0.000 description 1
- PEROROPTZQXUFQ-UHFFFAOYSA-N 1-butoxybutane;toluene Chemical compound CC1=CC=CC=C1.CCCCOCCCC PEROROPTZQXUFQ-UHFFFAOYSA-N 0.000 description 1
- WRNSAYACFKOUBH-UHFFFAOYSA-N 2-methyloxolane;1,2-xylene Chemical compound CC1CCCO1.CC1=CC=CC=C1C WRNSAYACFKOUBH-UHFFFAOYSA-N 0.000 description 1
- FNAYLSDQHZLYQB-UHFFFAOYSA-N 2-methyloxolane;toluene Chemical compound CC1CCCO1.CC1=CC=CC=C1 FNAYLSDQHZLYQB-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- ANIKGZRZMWNRAX-UHFFFAOYSA-N 3-(bromomethyl)heptane hydrobromide Chemical compound Br.CCCCC(CC)CBr ANIKGZRZMWNRAX-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OURXRFYZEOUCRM-UHFFFAOYSA-N 4-hydroxymorpholine Chemical compound ON1CCOCC1 OURXRFYZEOUCRM-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- PLZYVVWXSYGBAX-UHFFFAOYSA-M [Br-].CCCC(CCC)CCC[Mg+] Chemical compound [Br-].CCCC(CCC)CCC[Mg+] PLZYVVWXSYGBAX-UHFFFAOYSA-M 0.000 description 1
- 150000001243 acetic acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- FUGIIBWTNARRSF-UHFFFAOYSA-N decane-5,6-diol Chemical compound CCCCC(O)C(O)CCCC FUGIIBWTNARRSF-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000003168 generic drug Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- UCDWWJKPBQZZNT-UHFFFAOYSA-N magnesium;oxolane Chemical compound [Mg].C1CCOC1 UCDWWJKPBQZZNT-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000002901 organomagnesium compounds Chemical class 0.000 description 1
- 150000002917 oxazolidines Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/02—Magnesium compounds
Abstract
Description
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0523435.6 | 2005-11-17 | ||
GBGB0523435.6A GB0523435D0 (en) | 2005-11-17 | 2005-11-17 | Process |
PCT/GB2006/004293 WO2007057681A1 (en) | 2005-11-17 | 2006-11-17 | Process for the preparation of delmopinol and derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101309913A CN101309913A (zh) | 2008-11-19 |
CN101309913B true CN101309913B (zh) | 2011-05-25 |
Family
ID=35580225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800430395A Active CN101309913B (zh) | 2005-11-17 | 2006-11-17 | 制备地莫匹醇及其衍生物的方法 |
Country Status (20)
Country | Link |
---|---|
US (3) | US7902357B2 (zh) |
EP (1) | EP1948626B1 (zh) |
JP (1) | JP5202326B2 (zh) |
CN (1) | CN101309913B (zh) |
AT (1) | ATE424390T1 (zh) |
AU (1) | AU2006314309B2 (zh) |
BR (1) | BRPI0618675B1 (zh) |
CA (1) | CA2628921C (zh) |
CY (1) | CY1109049T1 (zh) |
DE (1) | DE602006005513D1 (zh) |
DK (1) | DK1948626T3 (zh) |
ES (1) | ES2321657T3 (zh) |
GB (1) | GB0523435D0 (zh) |
MY (1) | MY143867A (zh) |
NO (1) | NO20082617L (zh) |
NZ (1) | NZ568143A (zh) |
PL (1) | PL1948626T3 (zh) |
PT (1) | PT1948626E (zh) |
RU (1) | RU2404169C2 (zh) |
WO (1) | WO2007057681A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2715281T3 (es) | 2012-03-20 | 2019-06-03 | Merial Inc | Tratamiento de infecciones microbianas |
IT201600130538A1 (it) | 2016-12-23 | 2018-06-23 | Lundbeck Pharmaceuticals Italy S P A | Processo per la produzione del delmopinolo |
IT201600130642A1 (it) | 2016-12-23 | 2018-06-23 | Lundbeck Pharmaceuticals Italy S P A | Processo per la produzione di 2(3 alchilmorfolino)-etan-1-olo |
IT201600130729A1 (it) | 2016-12-23 | 2018-06-23 | Lundbeck Pharmaceuticals Italy S P A | Processo per la produzione degli intermedi del delmopinolo |
IT201700076821A1 (it) * | 2017-08-24 | 2019-02-24 | Lundbeck Pharmaceuticals Italy S P A | Nuovo sale del delmopinolo |
RU2696099C1 (ru) * | 2019-01-14 | 2019-07-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Хемоэнзиматический синтез производных 2,5-дикетоморфолина |
CA3169675A1 (en) * | 2020-01-31 | 2021-08-05 | You First Services, Inc. | Methods of making delmopinol and salts thereof |
CN112047964A (zh) * | 2020-09-07 | 2020-12-08 | 宋喂 | 格氏试剂制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0038785A1 (en) * | 1980-03-21 | 1981-10-28 | AB Ferrosan | Novel morpholino coumpounds |
CN1048218A (zh) * | 1989-05-24 | 1991-01-02 | 法马西亚制药公司 | 取代的异唑烷和异唑啉类化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2507425A1 (de) * | 1975-02-21 | 1976-09-02 | Hoechst Ag | Analoga von prostansaeuren und verfahren zu ihrer herstellung |
GB1603724A (en) * | 1977-05-25 | 1981-11-25 | Montedison Spa | Components and catalysts for the polymerisation of alpha-olefins |
FR2561648B1 (fr) * | 1984-03-26 | 1987-08-21 | Hoechst France | Nouvelles perhydro-oxazolo(2,3-c)oxazines-1,4, leur procede de preparation et leur application a l'obtention de glycines substituees |
US4675369A (en) * | 1984-09-05 | 1987-06-23 | Mobil Oil Corporation | Catalyst composition for polymerizing alpha-olefins at low reactants partial pressures |
-
2005
- 2005-11-17 GB GBGB0523435.6A patent/GB0523435D0/en not_active Ceased
-
2006
- 2006-11-17 JP JP2008540690A patent/JP5202326B2/ja active Active
- 2006-11-17 WO PCT/GB2006/004293 patent/WO2007057681A1/en active Application Filing
- 2006-11-17 US US12/092,825 patent/US7902357B2/en active Active - Reinstated
- 2006-11-17 PT PT06808580T patent/PT1948626E/pt unknown
- 2006-11-17 CN CN2006800430395A patent/CN101309913B/zh active Active
- 2006-11-17 PL PL06808580T patent/PL1948626T3/pl unknown
- 2006-11-17 ES ES06808580T patent/ES2321657T3/es active Active
- 2006-11-17 EP EP06808580A patent/EP1948626B1/en active Active
- 2006-11-17 NZ NZ568143A patent/NZ568143A/en unknown
- 2006-11-17 AT AT06808580T patent/ATE424390T1/de active
- 2006-11-17 CA CA2628921A patent/CA2628921C/en not_active Expired - Fee Related
- 2006-11-17 DK DK06808580T patent/DK1948626T3/da active
- 2006-11-17 BR BRPI0618675A patent/BRPI0618675B1/pt active IP Right Grant
- 2006-11-17 RU RU2008118067/04A patent/RU2404169C2/ru active
- 2006-11-17 DE DE602006005513T patent/DE602006005513D1/de active Active
- 2006-11-17 AU AU2006314309A patent/AU2006314309B2/en active Active
-
2008
- 2008-05-06 MY MYPI20081449A patent/MY143867A/en unknown
- 2008-06-12 NO NO20082617A patent/NO20082617L/no not_active Application Discontinuation
-
2009
- 2009-05-06 CY CY20091100486T patent/CY1109049T1/el unknown
-
2010
- 2010-05-13 US US12/779,288 patent/US7910730B2/en active Active
- 2010-12-20 US US12/972,955 patent/US8143463B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0038785A1 (en) * | 1980-03-21 | 1981-10-28 | AB Ferrosan | Novel morpholino coumpounds |
CN1048218A (zh) * | 1989-05-24 | 1991-01-02 | 法马西亚制药公司 | 取代的异唑烷和异唑啉类化合物 |
Non-Patent Citations (1)
Title |
---|
Hadi Poerwono,et al.Stereocontrolled Preparation of cis- and trans-2,6-Dialkylpiperidines via Diastereoselective Reaction of 1-Aza-4-oxabicyclo[4.3.0]nonane Derivatives with Grignard Reagents.Tetrahedron.1998,5413955-13970. * |
Also Published As
Publication number | Publication date |
---|---|
ATE424390T1 (de) | 2009-03-15 |
RU2404169C2 (ru) | 2010-11-20 |
EP1948626B1 (en) | 2009-03-04 |
US20090137798A1 (en) | 2009-05-28 |
CN101309913A (zh) | 2008-11-19 |
US20100222579A1 (en) | 2010-09-02 |
US7910730B2 (en) | 2011-03-22 |
PT1948626E (pt) | 2009-05-15 |
BRPI0618675B1 (pt) | 2016-03-29 |
NO20082617L (no) | 2008-06-12 |
BRPI0618675A2 (pt) | 2011-09-06 |
RU2008118067A (ru) | 2009-12-27 |
CY1109049T1 (el) | 2014-07-02 |
JP2009516674A (ja) | 2009-04-23 |
MY143867A (en) | 2011-07-15 |
US7902357B2 (en) | 2011-03-08 |
AU2006314309A1 (en) | 2007-05-24 |
NZ568143A (en) | 2010-04-30 |
WO2007057681A1 (en) | 2007-05-24 |
ES2321657T3 (es) | 2009-06-09 |
DE602006005513D1 (de) | 2009-04-16 |
EP1948626A1 (en) | 2008-07-30 |
GB0523435D0 (en) | 2005-12-28 |
CA2628921C (en) | 2013-01-08 |
DK1948626T3 (da) | 2009-05-18 |
PL1948626T3 (pl) | 2009-08-31 |
AU2006314309B2 (en) | 2009-12-24 |
US8143463B2 (en) | 2012-03-27 |
US20110092751A1 (en) | 2011-04-21 |
CA2628921A1 (en) | 2007-05-24 |
JP5202326B2 (ja) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101309913B (zh) | 制备地莫匹醇及其衍生物的方法 | |
CN106674264A (zh) | (2,2,2‑三氟乙氧基)苯硼酸类化合物的合成方法 | |
CZ185295A3 (en) | Optically active beta-aminoalkoxyborane complex | |
EP1213279B1 (en) | Venlafaxine production process | |
CN110563726A (zh) | 叔丁基-7,9-二氧亚基-2,6-二氮杂螺[4.5]癸烷-2-甲酸基酯的制备方法 | |
JP5448572B2 (ja) | アセチル化合物、該アセチル化合物の製造方法、および該アセチル化合物を使用したナフトール化合物の製造方法 | |
CN111825593B (zh) | 3-氨基吡咯-2-甲酰胺类化合物的合成方法 | |
JP4157361B2 (ja) | 9−スピロフルオレン化合物の製造方法 | |
JP2648297B2 (ja) | カルボジチオアート誘導体の製造方法 | |
JP5205971B2 (ja) | テトラヒドロピラン化合物の製造方法 | |
JP2023548682A (ja) | L-フェニルアラニンエステルの新規合成 | |
US7528276B2 (en) | Process for preparing the intermediate compounds for PPAR α ligands | |
JP2008120759A (ja) | エーテル基を有するβ−ジケトン化合物の製造法 | |
AU2019438654A1 (en) | Conjugated triene compound, preparation method therefor and use thereof | |
WO2005051897A1 (en) | Process for the preparation of tamsulosin | |
WO2020148780A1 (en) | Process for preparation of 4,4,4- trifluorobut-2-en-1-ol and intermediate thereof | |
CN112724015A (zh) | 脂环族丙烯酸衍生物的制备方法及包括其的组合物 | |
JPH09183755A (ja) | 2−オキソシクロペンタンカルボン酸エステルの製造方法 | |
JPS6393748A (ja) | 2−(4−置換フエニル)プロピオン酸誘導体の製造法 | |
MX2008006353A (en) | Process for the preparation of delmopinol and derivatives thereof | |
JP2004250348A (ja) | アルキルルテノセンの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170509 Address after: Wiltshire Patentee after: Mailer Research Ltd Address before: Surrey Patentee before: Sinclair Pharmaceuticals Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180518 Address after: Georgia Patentee after: Cimmeria limited-liability company Address before: Wiltshire Patentee before: Mailer Research Ltd |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190711 Address after: Georgia Patentee after: Bollinger Ingham Animal Health USA Address before: Georgia Patentee before: Cimmeria limited-liability company |